Skip to content

Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry

Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02870179
Enrollment
11
Registered
2016-08-17
Start date
2016-08-31
Completion date
2016-09-30
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia

Keywords

Pulse Oximetry, Temperature, Respiratory Rate, Respiratory Gases, This study determines the measurement accuracy of the physiological parameters

Brief summary

The purpose of this study is to conduct a SpO2 hypoxia evaluation of the Oxitone Medical Oxitone 1000 pulse oximeter. The Oxitone 1000 pulse oximeter will be evaluated during non-motion conditions over the range of 70-100% SpO2 in comparison to a Reference Pulse Oximeter. The study is observational in nature which quantifies device performance and accuracy in compassion to a Reference Pulse Oximeter.

Detailed description

The purpose of this study is to conduct a SpO2 hypoxia evaluation of the Oxitone Medical Oxitone 1000 pulse oximeter. The Oxitone 1000 pulse oximeter will be evaluated during non-motion conditions over the range of 70-100% SpO2 in comparison to a Reference Pulse Oximeter. The end goal is to show the SpO2 accuracy performance of the Oxitone 1000 and if needed, use the data to make improvements prior to an arterial blood hypoxia study. A Clinimark 3900 Reference Pulse Oximeter or Nellcor N-600x will be used for the SpO2 calibration. There are no risks or adverse device effects to be assessed. There are no contraindications for use in the proposed study / study population The Control Pulse Oximeter, GE Healthcare (Datex-Ohmeda) 3900, an FDA cleared device, is used to monitor the oxygen saturation levels real time throughout the study for subject safety and to target stable plateaus. This device is used to assess the stability of the data.

Interventions

DEVICEPulse Oximeter

Measurement of physiological parameters

Sponsors

Clinimark, LLC
CollaboratorOTHER
Oxitone Medical Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals between the age of 18-50

Exclusion criteria

* Clotting disorders, diabetes, currently taking psychotropic medications

Design outcomes

Primary

MeasureTime frameDescription
Collect SpO2 data for accuracy statistical analysis by 12 subjects2 monthsData is collected in a digital form for 4-6 SpO2 stable plateaus in a specified range from 100% to 70%.
Accuracy data analysis2 monthsBland-Altman graphical plots. An Accuracy Root Mean Square (ARMS) calculation is used as a means to define the SpO2 accuracy. Data analysis will follow ISO80601-2-61, Annex EE and the FDA Guidance Document for Pulse Oximeters (Martch 4, 2013).

Secondary

MeasureTime frameDescription
Error plots2 monthsSpO2 versus (SpO2-Ref SpO2) will be generated with linear regression fit, mean, and upper 95% and lower 95% limits of agreement.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026